Guido Davidzon
Lead, Targeted Radionuclide Therapy Program · Stanford Health Care
Credentials: · · · · ·
History
Present- Present
- Present
- 2012–2013
Stanford University Radiology Fellowships (2013) CA
- 2002–2005
- 1998–2002
Doctor of Medicine
Research
Review · Annals of Medicine · 2005 · 242 citations
Early-onset familial parkinsonism due to POLG mutations
Case report · Annals of Neurology · 2006 · First of 7 authors · 189 citations
Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights
Journal of Neuropathology & Experimental Neurology · 2005 · 108 citations
35 papers
20 papers
15 papers
11 papers · 10 as a resident
- NH
11 papers · 4 as a resident
10 papers
8 papers
8 papers
Grants
- 2019–2021
Sigma-1 Receptors: A Novel Clinical Target in Fragile X Syndrome
National Institute of Child Health and Human Development · R21
Contact PI · $195.6K · Stanford University
Clinical trials
- 2021–2022
Novel Clinical Target in Fragile X Syndrome
Principal investigator · Withdrawn · Phase 1
Guido A. Davidzon, MD, SM
- 2018–2022
Principal investigator · Terminated · Phase 1
Guido A. Davidzon, MD, SM
- 2017–2021
Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT
Principal investigator · Completed
Stanford University